KIT
Drug: Imatinib
Cancer code: LAML
Cancer type: acute_myeloid_leukaemia
Drug treatment table
| Cell line ID |
Cell line name |
Mutation in substructure |
IC50(uM) |
| SIDM01005 | KASUMI-1 | A_loop (822) | 23.4979 |
| SIDM00951 | CTV-1 | None | 8.7275 |
| SIDM00829 | HL-60 | None | 27.5423 |
| SIDM01057 | GDM-1 | None | 1.0727 |
| SIDM00594 | HEL | None | 13.6517 |
| SIDM00785 | KG-1 | None | 19.7629 |
| SIDM01019 | KMOE-2 | None | 16.6627 |
| SIDM00441 | ML-2 | None | 17.664 |
| SIDM01023 | MONO-MAC-6 | None | 27.2199 |
| SIDM00576 | NKM-1 | None | 9.7021 |
| SIDM00580 | NOMO-1 | None | 26.083 |
| SIDM00363 | P31-FUJ | None | 14.9169 |
| SIDM00396 | SIG-M5 | None | 7.473 |
| SIDM01172 | THP-1 | None | 13.7788 |
| SIDM00467 | QIMR-WIL | None | 22.0771 |
| SIDM00959 | CMK | None | 13.2447 |
| SIDM00917 | CESS | None | 14.9928 |
| SIDM00446 | OCI-AML2 | None | 9.248 |
| SIDM00462 | OCI-AML3 | None | 14.9235 |
| SIDM00428 | NB4 | None | 11.4648 |
| SIDM00338 | ME-1 | None | 33.0096 |
| SIDM00437 | MOLM-13 | None | 5.0677 |
| SIDM00461 | OCI-AML5 | None | 7.1662 |
| SIDM00458 | OCI-M1 | None | 9.7745 |
| SIDM00450 | PL-21 | None | 36.4973 |
